Tisdale, John F.

Neurogenesis in the striatum of the adult human brain

Ernst, A., Alkass, K., Bernard, S., Salehpour, M., Perl, S., Tisdale, J., Possnert, G., Druid, H., & Frisén, J. (2014) · Cell

Neurogenesis and neuroplasticity mechanismsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 937

Dynamics of Oligodendrocyte Generation and Myelination in the Human Brain

Yeung, M. S. Y., Zdunek, S., Bergmann, O., Bernard, S., Salehpour, M., Alkass, K., Perl, S., Tisdale, J., Possnert, G., Brundin, L., et al. (2014) · Cell

Neurogenesis and neuroplasticity mechanismsMultiple Sclerosis Research Studies

Cited by 541

The Lifespan and Turnover of Microglia in the Human Brain

Réu, P., Khosravi, A., Bernard, S., Mold, J. E., Salehpour, M., Alkass, K., Perl, S., Tisdale, J., Possnert, G., Druid, H., et al. (2017) · Cell Reports

Neuroinflammation and Neurodegeneration MechanismsNeurogenesis and neuroplasticity mechanisms

Cited by 515

Significant Human β-Cell Turnover Is Limited to the First Three Decades of Life as Determined by in Vivo Thymidine Analog Incorporation and Radiocarbon Dating

Perl, S., Kushner, J. A., Buchholz, B. A., Meeker, A. K., Stein, G. M., Hsieh, M., Kirby, M., Pechhold, S., Liu, E. H., Harlan, D. M., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism

Pancreatic function and diabetesDiabetes and associated disorders

Cited by 241

Genome editing of HBG1 and HBG2 to induce fetal hemoglobin

Métais, J.-Y., Doerfler, P. A., Mayuranathan, T., Bauer, D. E., Fowler, S. C., Hsieh, M. M., Katta, V., Keriwala, S., Lazzarotto, C. R., Luk, K., et al. (2019) · Blood Advances

Hemoglobinopathies and Related DisordersCRISPR and Genetic Engineering

Cited by 177

HIF prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques

Hsieh, M. M., Linde, N. S., Wynter, A., Metzger, M., Wong, C., Langsetmo, I., Lin, A., Smith, R., Rodgers, G. P., Donahue, R. E., et al. (2007) · Blood

Erythropoietin and Anemia TreatmentHemoglobinopathies and Related Disorders

Cited by 171

Myelodysplastic syndrome unrelated to lentiviral vector in a patient treated with gene therapy for sickle cell disease

Hsieh, M. M., Bonner, M., Pierciey, F. J., Uchida, N., Rottman, J., Demopoulos, L., Schmidt, M., Kanter, J., Walters, M. C., Thompson, A. A., et al. (2020) · Blood Advances

Virus-based gene therapy researchHemoglobinopathies and Related Disorders

Cited by 152

Cerebrovascular disease associated with sickle cell pulmonary hypertension

Kato, G. J., Hsieh, M., Machado, R., Taylor, J., Little, J., Butman, J. A., Lehky, T., Tisdale, J., & Gladwin, M. T. (2006) · American Journal of Hematology

Hemoglobinopathies and Related DisordersPulmonary Hypertension Research and Treatments

Cited by 100

Hydroxyurea-Increased fetal hemoglobin Is associated with less organ damage and longer survival in adults with sickle cell anemia

Fitzhugh, C. D., Hsieh, M. M., Allen, D., Coles, W. A., Seamon, C., Ring, M., Zhao, X., Minniti, C. P., Rodgers, G. P., Schechter, A. N., et al. (2015) · PLOS ONE

Hemoglobinopathies and Related DisordersBlood groups and transfusion

Cited by 64

Cas9 protein delivery non-integrating lentiviral vectors for gene correction in sickle cell disease

Uchida, N., Drysdale, C. M., Nassehi, T., Gamer, J., Yapundich, M., DiNicola, J., Shibata, Y., Hinds, M., Gudmundsdottir, B., Haro-Mora, J. J., et al. (2021) · Molecular Therapy - Methods & Clinical Development

Virus-based gene therapy researchCRISPR and Genetic Engineering

Cited by 55

Curative options for sickle cell disease: haploidentical stem cell transplantation or gene therapy?

Leonard, A., Tisdale, J., & Abraham, A. (2020) · British Journal of Haematology

Hemoglobinopathies and Related DisordersHematopoietic Stem Cell Transplantation

Cited by 45

Resolution of Sickle Cell Disease Manifestations in Patients Treated with Lentiglobin Gene Therapy: Updated Results from the Phase 1/2 Hgb-206 Group C Study

Kanter, J., Tisdale, J. F., Mapara, M. Y., Kwiatkowski, J. L., Krishnamurti, L., Schmidt, M., Miller, A. L., Pierciey, F. J., Huang, W., Ribeil, J.-A., et al. (2019) · Blood

Hemoglobinopathies and Related DisordersVirus-based gene therapy research

Cited by 21

Efficacy, Safety, and Health-Related Quality of Life (HRQOL) in Patients with Sickle Cell Disease (SCD) Who Have Received Lovotibeglogene Autotemcel (Lovo-cel) Gene Therapy: Up to 60 Months of Follow-up

Kanter, J., Thompson, A. A., Kwiatkowski, J. L., Parikh, S., Mapara, M., Rifkin-Zenenberg, S., Aygun, B., Kasow, K. A., Gupta, A. O., Zhang, L., et al. (2023) · Blood

Hemoglobinopathies and Related DisordersNeurogenetic and Muscular Disorders Research

Cited by 15

Chronic administration of hydroxyurea (HU) benefits caucasian patients with sickle-beta thalassemia

Di Maggio, R., Hsieh, M., Zhao, X., Calvaruso, G., Rigano, P., Renda, D., Tisdale, J., & Maggio, A. (2018) · International Journal of Molecular Sciences

Hemoglobinopathies and Related DisordersBlood groups and transfusion

Cited by 12

Transient In Vivo β-Globin Production After Lentiviral Gene Transfer to Hematopoietic Stem Cells in the Nonhuman Primate

Hayakawa, J., Ueda, T., Lisowski, L., Hsieh, M. M., Washington, K., Phang, O., Metzger, M., Krouse, A., Donahue, R. E., Sadelain, M., et al. (2009) · Human Gene Therapy

Virus-based gene therapy researchHematopoietic Stem Cell Transplantation

Cited by 9